{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:30:12Z","timestamp":1786609812192,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00595-026-03303-2","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:14:21Z","timestamp":1776770061000},"page":"1856-1867","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet count as a prognostic biomarker in resected hepatocellular carcinoma: differential impact of thrombocytosis and thrombocytopenia by btiology and fibrosis"],"prefix":"10.1007","volume":"56","author":[{"given":"Takashi","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiro","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-0454","authenticated-orcid":false,"given":"Toru","family":"Beppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsunori","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"Suppl 1","key":"3303_CR1","first-page":"4","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiol Hepatocellular Carcinoma Hepatol. 2021;73(Suppl 1):4\u201313.","journal-title":"Epidemiol Hepatocellular Carcinoma Hepatol"},{"key":"3303_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-024-00500-6","volume":"10","author":"JM Llovet","year":"2024","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Author correction: hepatocellular carcinoma. Nat Rev Dis Primers. 2024;10:10.","journal-title":"Nat Rev Dis Primers"},{"key":"3303_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05444-z","volume":"12","author":"M Nakano","year":"2022","unstructured":"Nakano M, Yatsuhashi H, Bekki S, Takami Y, Tanaka Y, Yoshimaru Y, et al. Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019. Sci Rep. 2022;12:1517.","journal-title":"Sci Rep"},{"key":"3303_CR4","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/hepr.14147","volume":"55","author":"K Okushin","year":"2025","unstructured":"Okushin K, Tateishi R, Hirakawa S, Tachimori H, Uchino K, Nakagomi R, et al. Comparable outcomes among etiologies in early-stage hepatocellular carcinoma: analysis of a nationwide registry in Japan. Hepatol Res. 2025;55:556\u201366.","journal-title":"Hepatol Res"},{"key":"3303_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071293","author":"L Kraj","year":"2024","unstructured":"Kraj L, Chmiel P, Gryziak M, Grabowska-Derlatka L, Szymanski L, Wysokinska E. Impact of thrombocytopenia on survival in patients with hepatocellular carcinoma: updated meta-analysis and systematic review. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16071293.","journal-title":"Cancers (Basel)"},{"key":"3303_CR6","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u20138.","journal-title":"N Engl J Med"},{"key":"3303_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3109\/09537104.2016.1170112","volume":"27","author":"Z Baranyai","year":"2016","unstructured":"Baranyai Z, Josa V, Toth A, Szilasi Z, Tihanyi B, Zarand A, et al. Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets. 2016;27:269\u201375.","journal-title":"Platelets"},{"key":"3303_CR8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1097\/MEG.0000000000002341","volume":"34","author":"Y Ulger","year":"2022","unstructured":"Ulger Y, Delik A. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients. Eur J Gastroenterol Hepatol. 2022;34:769\u201373.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3303_CR9","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1111\/liv.14560","volume":"40","author":"PH Liu","year":"2020","unstructured":"Liu PH, Hsu CY, Su CW, Huang YH, Hou MC, Rich NE, et al. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma. Liver Int. 2020;40:2522\u201334.","journal-title":"Liver Int"},{"key":"3303_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5582\/bst.2025.01067","volume":"19","author":"X Wang","year":"2025","unstructured":"Wang X, Wang P, Tang B, Xu J, Wang B, Gu L, et al. Platelet count as a double-edged sword: the impact of thrombocytosis and thrombocytopenia on long-term outcomes after hepatic resection for hepatocellular carcinoma. Biosci Trends. 2025;19:351\u201360.","journal-title":"Biosci Trends"},{"key":"3303_CR11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/jhbp.114","volume":"21","author":"K Yamamura","year":"2014","unstructured":"Yamamura K, Sugimoto H, Kanda M, Yamada S, Nomoto S, Nakayama G, et al. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection. J Hepatobiliary Pancreat Sci. 2014;21:682\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3303_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7018","volume":"13","author":"S She","year":"2024","unstructured":"She S, Shi J, Zhu J, Yang F, Yu J, Dai K. Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy. Cancer Med. 2024;13:e7018.","journal-title":"Cancer Med"},{"key":"3303_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/hepr.12835","volume":"47","author":"T Kaida","year":"2017","unstructured":"Kaida T, Nitta H, Kitano Y, Yamamura K, Arima K, Higashi T, et al. Preoperative platelet-to-lymphocyte ratio can predict recurrence beyond the Milan criteria after hepatectomy for patients with hepatocellular carcinoma. Hepatol Res. 2017;47:991\u20139.","journal-title":"Hepatol Res"},{"key":"3303_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10147-024-02646-5","volume":"30","author":"T Matsumoto","year":"2025","unstructured":"Matsumoto T, Kitano Y, Imai K, Ogawa D, Yumoto S, Takematsu T, et al. Prognostic impact of aspirin in patients with hepatocellular carcinoma after liver resection: propensity-score-matched analysis. Int J Clin Oncol. 2025;30:92\u20138.","journal-title":"Int J Clin Oncol"},{"key":"3303_CR15","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67:93\u20139.","journal-title":"CA Cancer J Clin"},{"key":"3303_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2147\/JHC.S511263","volume":"12","author":"S Munker","year":"2025","unstructured":"Munker S, Rodriguez I, Bernhart K, Ben Khaled N, Findik M, Siegmund LK, et al. Prognostic Significance of Elevated Platelet Count (>\u2009200 x 10;9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis. J Hepatocell Carcinoma. 2025;12:855\u201364.","journal-title":"J Hepatocell Carcinoma"},{"key":"3303_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","volume":"7","author":"N Mendez-Sanchez","year":"2022","unstructured":"Mendez-Sanchez N, Bugianesi E, Gish RG, Lammert F, Tilg H, Nguyen MH, et al. Global multi-stakeholder endorsement of the MAFLD definition. Lancet Gastroenterol Hepatol. 2022;7:388\u201390.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3303_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0928-4346(96)00325-8","volume":"6","author":"F Ichida","year":"1996","unstructured":"Ichida F, Tsuji T, Omata M, Ichida T, Inoue K, Kamimura T, et al. New inuyama classification; new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6:112\u20139.","journal-title":"Int Hepatol Commun"},{"key":"3303_CR19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00595-021-02427-x","volume":"52","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Kitano Y, Imai K, Kinoshita S, Sato H, Shiraishi Y, et al. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy. Surg Today. 2022;52:1008\u201315.","journal-title":"Surg Today"},{"key":"3303_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00595-017-1553-3","volume":"48","author":"H Wada","year":"2018","unstructured":"Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M, et al. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surg Today. 2018;48:73\u20139.","journal-title":"Surg Today"},{"key":"3303_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1440-1746.2009.06031.x","volume":"25","author":"M Tomikawa","year":"2010","unstructured":"Tomikawa M, Akahoshi T, Sugimachi K, Ikeda Y, Yoshida K, Tanabe Y, et al. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism. J Gastroenterol Hepatol. 2010;25:397\u2013402.","journal-title":"J Gastroenterol Hepatol"},{"key":"3303_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/hepr.14142","volume":"55","author":"T Beppu","year":"2025","unstructured":"Beppu T, Masuda T, Imai K, Hayashi H. Clinical benefits of partial splenic embolization for cancer patients. Hepatol Res. 2025;55:4\u201311.","journal-title":"Hepatol Res"},{"key":"3303_CR23","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1007\/s10620-012-2527-3","volume":"58","author":"BI Carr","year":"2013","unstructured":"Carr BI, Guerra V. Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci. 2013;58:1790\u20136.","journal-title":"Dig Dis Sci"},{"key":"3303_CR24","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.3390\/cimb46060356","volume":"46","author":"Y Shi","year":"2024","unstructured":"Shi Y, Taherifard E, Saeed A, Saeed A. MASLD-related HCC: a comprehensive review of the trends, pathophysiology, tumor microenvironment, surveillance, and treatment options. Curr Issues Mol Biol. 2024;46:5965\u201383.","journal-title":"Curr Issues Mol Biol"},{"key":"3303_CR25","doi-asserted-by":"publisher","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","volume":"109","author":"G Sitia","year":"2012","unstructured":"Sitia G, Aiolfi R, Di Lucia P, Mainetti M, Fiocchi A, Mingozzi F, et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A. 2012;109:E2165\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3303_CR26","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1158\/0008-5472.CAN-21-0758","volume":"81","author":"E Ricciotti","year":"2021","unstructured":"Ricciotti E, Wangensteen KJ, FitzGerald GA. Aspirin in hepatocellular carcinoma. Cancer Res. 2021;81:3751\u201361.","journal-title":"Cancer Res"},{"key":"3303_CR27","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/hep.29318","volume":"66","author":"M Lee","year":"2017","unstructured":"Lee M, Chung GE, Lee JH, Oh S, Nam JY, Chang Y, et al. Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment. Hepatology. 2017;66:1556\u201369.","journal-title":"Hepatology"},{"key":"3303_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102065","volume":"61","author":"TY Lee","year":"2023","unstructured":"Lee TY, Hsu YC, Ho HJ, Lin JT, Chen YJ, Wu CY. Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study. EClinicalMedicine. 2023;61:102065.","journal-title":"EClinicalMedicine"},{"key":"3303_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1245\/s10434-016-5520-9","volume":"23","author":"PC Lee","year":"2016","unstructured":"Lee PC, Yeh CM, Hu YW, Chen CC, Liu CJ, Su CW, et al. Antiplatelet therapy is associated with a better prognosis for patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after liver resection. Ann Surg Oncol. 2016;23:874\u201383.","journal-title":"Ann Surg Oncol"},{"key":"3303_CR30","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s00535-014-0973-8","volume":"50","author":"R Tateishi","year":"2015","unstructured":"Tateishi R, Okanoue T, Fujiwara N, Okita K, Kiyosawa K, Omata M, et al. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study. J Gastroenterol. 2015;50:350\u201360.","journal-title":"J Gastroenterol"},{"key":"3303_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48812-z","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang M, Liu C, Hao M, Wang W, Li Y, et al. Hepatoprotective effects of aspirin on diethylnitrosamine-induced hepatocellular carcinoma in rats by reducing inflammation levels and PD-L1 expression. Sci Rep. 2023;13:21362.","journal-title":"Sci Rep"},{"key":"3303_CR32","doi-asserted-by":"publisher","first-page":"3572","DOI":"10.3748\/wjg.v23.i20.3572","volume":"23","author":"P Martin-Sanz","year":"2017","unstructured":"Martin-Sanz P, Casado M, Bosca L. Cyclooxygenase 2 in liver dysfunction and carcinogenesis: facts and perspectives. World J Gastroenterol. 2017;23:3572\u201380.","journal-title":"World J Gastroenterol"},{"key":"3303_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00595-024-02980-1","volume":"55","author":"T Yamamoto","year":"2025","unstructured":"Yamamoto T, Takahashi A, Yoshizumi T, Ishihara S, Inomata M, Imoto S, et al. 2023 national clinical database annual report by the Japan Surgical Society. Surg Today. 2025;55:295\u2013334.","journal-title":"Surg Today"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03303-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03303-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:01:08Z","timestamp":1786608068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03303-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["3303"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03303-2","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"31 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that no conflict of interest exists in this study.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}